Figure 3.

The disease-free survival (DFS) of patients with advanced-stage tumours (stages III and IV), grouped by apoptotic cell rates. Patients with high AIs (lower line) present shorter survival durations than patients with low AIs (upper line).

Alcaide et al. BMC Clinical Pathology 2013 13:24   doi:10.1186/1472-6890-13-24
Download authors' original image